AI assistant
Sending…
ARVINAS, INC. — Director's Dealing 2025
Mar 19, 2025
32625_dirs_2025-03-19_23798205-9e12-4565-a588-4abf4c0289e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2025-03-18
Reporting Person: Berkowitz Noah (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-18 | Common Stock | S | 8658 | $8.59 | Disposed | 110023 | Direct |
Footnotes
F1: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on March 18, 2024.
More from ARVINAS, INC.
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3